Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Andresen

Showing results (141-150 of 227) with videos related to

Pageof 23
Sort By:
Cancer Research|February 1, 1991
Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapyM J Thomassen, M Ahmad, B P Barna, et al.
Bone Marrow Transplantation|March 23, 2010
Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCTD M Mickelson, L Sproat, R Dean, et al.
American Journal of Human Genetics|September 1, 1993
A rare disease-associated mutation in the medium-chain acyl-CoA dehydrogenase (MCAD) gene changes a conserved arginine, previously shown to be functionally essential in short-chain acyl-CoA dehydrogenase (SCAD)B S Andresen, P Bross, T G Jensen, et al.
Human Genetics|August 1, 1991
The most common mutation causing medium-chain acyl-CoA dehydrogenase deficiency is strongly associated with a particular haplotype in the region of the geneS Kølvraa, N Gregersen, A I Blakemore, et al.
Bone Marrow Transplantation|July 20, 2004
Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction?W H W Tang, S Thomas, M Kalaycio, et al.
Bone Marrow Transplantation|February 2, 2000
High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipientsR Avery, B Pohlman, K Adal, et al.
Bone Marrow Transplantation|July 10, 2007
Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignanciesB J Bolwell, B Pohlman, L Rybicki, et al.
Molecular Genetics and Metabolism|November 18, 2018
Next generation sequencing of RNA reveals novel targets of resveratrol with possible implications for Canavan diseaseMaja Dembic, Henriette S Andersen, Jean Bastin, et al.
Human Mutation|January 1, 1995
Comparison between medium-chain acyl-CoA dehydrogenase mutant proteins overexpressed in bacterial and mammalian cellsT G Jensen, P Bross, B S Andresen, et al.
NAR Molecular Medicine|November 21, 2025
Oligonucleotides targeting the 3' splice site downstream of a microexon as an innovative therapy for autismAinhoa Martinez-Pizarro, Sara Picó, Mar Alvárez, et al.
Pageof 23

Showing results (141-150 of 227) with videos related to

Sort By:
Pageof 23
Cancer Research|February 1, 1991
Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapyM J Thomassen, M Ahmad, B P Barna, et al.
Bone Marrow Transplantation|March 23, 2010
Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCTD M Mickelson, L Sproat, R Dean, et al.
American Journal of Human Genetics|September 1, 1993
A rare disease-associated mutation in the medium-chain acyl-CoA dehydrogenase (MCAD) gene changes a conserved arginine, previously shown to be functionally essential in short-chain acyl-CoA dehydrogenase (SCAD)B S Andresen, P Bross, T G Jensen, et al.
Human Genetics|August 1, 1991
The most common mutation causing medium-chain acyl-CoA dehydrogenase deficiency is strongly associated with a particular haplotype in the region of the geneS Kølvraa, N Gregersen, A I Blakemore, et al.
Bone Marrow Transplantation|July 20, 2004
Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction?W H W Tang, S Thomas, M Kalaycio, et al.
Bone Marrow Transplantation|February 2, 2000
High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipientsR Avery, B Pohlman, K Adal, et al.
Bone Marrow Transplantation|July 10, 2007
Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignanciesB J Bolwell, B Pohlman, L Rybicki, et al.
Molecular Genetics and Metabolism|November 18, 2018
Next generation sequencing of RNA reveals novel targets of resveratrol with possible implications for Canavan diseaseMaja Dembic, Henriette S Andersen, Jean Bastin, et al.
Human Mutation|January 1, 1995
Comparison between medium-chain acyl-CoA dehydrogenase mutant proteins overexpressed in bacterial and mammalian cellsT G Jensen, P Bross, B S Andresen, et al.
NAR Molecular Medicine|November 21, 2025
Oligonucleotides targeting the 3' splice site downstream of a microexon as an innovative therapy for autismAinhoa Martinez-Pizarro, Sara Picó, Mar Alvárez, et al.
Pageof 23